Brief: Tonix Pharmaceuticals Awarded $34 Mln US Department Of Defense Contract For Accelerated Development Of Broad-Spectrum Antiviral Program

Tonix Pharmaceuticals Holding

01/07/2024 13:07

July 1 (Reuters) - Tonix Pharmaceuticals Holding Corp
 TNXP.O :
    * TONIX PHARMACEUTICALS AWARDED UP TO $34 MILLION U.S.
DEPARTMENT
OF DEFENSE CONTRACT FOR ACCELERATED DEVELOPMENT OF
BROAD-SPECTRUM ANTIVIRAL PROGRAM
    * TONIX PHARMACEUTICALS HOLDING CORP - CONTRACT TO DEVELOP
SMALL
MOLECULE BROAD-SPECTRUM ANTIVIRAL AGENTS
    * TONIX PHARMACEUTICALS HOLDING CORP - PROGRAM TO DEVELOP
ORALLY
AVAILABLE CD45 ANTAGONIST

Source text for Eikon:  ID:nGNX57RX6L 
Further company coverage:  TNXP.O 

 ((Reuters.Briefs@thomsonreuters.com;))